Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early levosimendan versus usual care in advanced chronic heart failure
2009-016958-41Phase 3Terminated
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of levosimendan and furosemide in chronic heart failure (CHF) (2 arms), sponsored by ASST Grande Ospedale Metropolitano Niguarda. Primary endpoint: Number of days alive free of transplant and out-of-hospital at 12 months. Started Jan 2010; status: terminated.
02
Drugs
levosimendanfurosemide
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2009-016958-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016958-41.